Retatrutide represents the cutting edge of metabolic research, functioning as a powerful triple agonist that targets GLP-1, GIP, and glucagon receptors. This "triple-threat" mechanism not only regulates blood sugar and suppresses appetite but also enhances energy expenditure by stimulating glucagon receptors in the liver.
Retatrutide represents the cutting edge of metabolic research, functioning as a powerful triple agonist that targets GLP-1, GIP, and glucagon receptors. This "triple-threat" mechanism not only regulates blood sugar and suppresses appetite but also enhances energy expenditure by stimulating glucagon receptors in the liver.